Early Lactate Clearance Rate in Sepsis

Early Lactate Clearance Clinical Trial

Official title:

Monitoring and Guidance of Early Lactate Clearance Rate in Patients With Sepsis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04192279
• Other study ID #: 78247891400
• Status: Recruiting
• Start date: January 1, 2015
• Est. completion date: February 15, 2020

Study information

• Verified date: December 2019
• Source: The Second Hospital of Hebei Medical University
• Contact: Fei Tong, Dr.
• Phone: +8615803210603
• Email: tongfei168[@]163.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To assess the Influence of early lactate clearance rate monitoring in patients with sepsis.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 220
• Est. completion date: February 15, 2020
• Est. primary completion date: January 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All patients whose blood lactate level reached or exceeded 2.0 mEq / L

Exclusion Criteria:

• Incomplete clinical data

Related Conditions & MeSH terms

• Early Lactate Clearance
• Sepsis

Intervention

Diagnostic Test:
• lactate clearance
Lactate clearance rate was monitored within 6 hours after admission

Locations

Country	Name	City	State
China	The Second Hospital of Hebei Medical University	Shijiazhuang	Hebei

Sponsors (1)

Lead Sponsor	Collaborator
The Second Hospital of Hebei Medical University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	In-hospital 60days mortality	In-hospital up to 60 days mortality of sepsis	In-hospital 60 days
Primary	ICU mortality	ICU up to 30 days mortality of sepsis	up to 30 days